SeaSpine Holdings Corporation

SeaSpine Holdings Corporation

SPNE

SPNESeaSpine Holdings Corporation US flag

NASDAQ Global Select

9.54

USD

+0.73

- -

SeaSpine Holdings Corporation

SPNE

(NASDAQ Global Select)

Recent

price

9.54

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Similar Companies: Lumexa Imaging Holdings, Inc. Common Stock (LMRI)
BICO Group AB (publ) (BCCOY)
Getein Biotech, Inc (603387.SS)
Integer Holdings Corporation (ITGR)
Sonova Holding AG (SOON.SW)
Drägerwerk AG & Co. KGaA (DRWKF)
Business: SeaSpine Holdings Corporation (SPNE) develops, manufactures, and markets a portfolio of spinal implant and orthobiologics products for spinal fusion surgeries worldwide. The company's core offerings include structural allografts and xenografts such as tetrasite, an osteoinductive bone growth protein; orthobiologics products like demineralized bone matrix and cellular bone allografts; and metallic and non-metallic spinal implants encompassing interbody fusion devices, plates, screws, and motion preservation systems. SeaSpine serves orthopedic surgeons, neurosurgeons, and spine specialists in hospitals and ambulatory surgical centers across the United States, Europe, and select international markets. Founded in 2015 and headquartered in Carlsbad, California, SeaSpine operates as an independent entity following its separation from Integra LifeSciences Holdings Corporation in 2017 and subsequent merger with NuVasive, Inc. in 2023, which expanded its product portfolio and market reach in minimally invasive spine technologies. In recent years, the company has focused on strategic expansions, including the launch of advanced orthobiologics platforms and enhancements to its Mariner and XO spinal systems to address degenerative disc disease, complex spine deformities, and trauma cases.

Company News